Premium
Pathological variables determining the prognosis of non‐Hodgkin's lymphomas
Author(s) -
KELLY S.A.,
HARKIN P.J.R.,
JACK A.S.
Publication year - 1992
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/j.1365-2559.1992.tb00961.x
Subject(s) - pathological , working formulation , immunophenotyping , medicine , lymphoma , pathology , oncology , non hodgkin's lymphoma , immunology , flow cytometry
The aim of the study was to assess the role of pathological grade, cell proliferation, ploidy, immunophenotype and site in determining the prognosis of non‐Hodgkin's lymphomas. Of particular interest was the relative value of grades derived from the Kiel classification as opposed to the National Cancer Institute (NCI) working formulation. The study consisted of 181 cases, treated in a relatively uniform way over an 18‐month period spanning 1986. Using life table analysis, both NCI working formulation grade and Kiel grade correlated strongly with survival. However, the differences between grades were entirely due to an excess of early deaths in the high‐grade and intermediate‐grade categories. In patients surviving greater than 0.1 years (37 days), phenotype, site, ploidy and cell proliferation had no effect on survival. There was no evidence that intermediate‐grade tumours, when subdivided into Kiel low‐ and high‐grade types, differed in survival from tumours graded as low‐ or high‐grade by both methods. However, NCI working formulation high‐grade tumours, especially those with a high proliferation rate, formed a group with a very high likelihood of death within 0.1 years.